Login / Signup

Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.

Rona M SmithRachel B JonesUlrich SpecksSimon BondMarianna NodaleReem Al-JayyousiJacqueline AndrewsAnnette BruchfeldBrian CamilleriSimon CaretteChee Kay CheungVimal DerebailTim DoultonAlastair FerraroLindsy ForbessShouichi FujimotoShunsuke FurutaOra Gewurz-SingerLorraine HarperToshiko Ito-IharaNader A KhalidiRainer KlockeCurry KoeningYoshinori KomagataCarol LangfordPeter LanyonRaashid LuqmaniCarol McAlearLarry W MorelandKim MynardPatrick NachmanChristian PagnouxChen Au PehCharles PuseyDwarakanathan RanganathanRennie L RheeRobert F SpieraAntoine G SreihVladamir TesarGiles D WaltersCaroline WroeDavid R W JaynePeter A Merkelnull null
Published in: Annals of the rheumatic diseases (2023)
NCT01697267; ClinicalTrials.gov identifier.
Keyphrases
  • disease activity
  • multiple sclerosis
  • study protocol
  • diffuse large b cell lymphoma
  • rheumatoid arthritis
  • systemic lupus erythematosus
  • hodgkin lymphoma
  • clinical trial
  • randomized controlled trial